Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jensen

Showing results (451-460 of 490) with videos related to

Pageof 49
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2007
Molecular markers of early Parkinson's disease based on gene expression in bloodClemens R Scherzer, Aron C Eklund, Lee J Morse, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2018
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancerA K Boysen, B S Sørensen, A C Lefevre, et al.
Plos One|May 21, 2010
Second generation sequencing of the mesothelioma tumor genomeRaphael Bueno, Assunta De Rienzo, Lingsheng Dong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stentLars Jakobsen, Evald H Christiansen, Phillip Freeman, et al.
Cell|February 11, 1998
Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivoR Sprengel, B Suchanek, C Amico, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2020
Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register studyLouise S Rasmussen, Claus W Fristrup, Benny V Jensen, et al.
Archives of Neurology|June 16, 2005
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonismMichael A Hauser, Yi-Ju Li, Hong Xu, et al.
Plos One|October 21, 2014
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without BevacizumabMogens K Boisen, Christian Dehlendorff, Dorte Linnemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2022
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)Inna M Chen, Julia S Johansen, Susann Theile, et al.
The American Journal of Cardiology|October 26, 2024
Comparison of Outcome After Percutaneous Coronary Intervention for De Novo and In-Stent Restenosis IndicationsLars Jakobsen, Evald H Christiansen, Phillip Freeman, et al.
Pageof 49

Showing results (451-460 of 490) with videos related to

Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2007
Molecular markers of early Parkinson's disease based on gene expression in bloodClemens R Scherzer, Aron C Eklund, Lee J Morse, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2018
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancerA K Boysen, B S Sørensen, A C Lefevre, et al.
Plos One|May 21, 2010
Second generation sequencing of the mesothelioma tumor genomeRaphael Bueno, Assunta De Rienzo, Lingsheng Dong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stentLars Jakobsen, Evald H Christiansen, Phillip Freeman, et al.
Cell|February 11, 1998
Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivoR Sprengel, B Suchanek, C Amico, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2020
Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register studyLouise S Rasmussen, Claus W Fristrup, Benny V Jensen, et al.
Archives of Neurology|June 16, 2005
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonismMichael A Hauser, Yi-Ju Li, Hong Xu, et al.
Plos One|October 21, 2014
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without BevacizumabMogens K Boisen, Christian Dehlendorff, Dorte Linnemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2022
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)Inna M Chen, Julia S Johansen, Susann Theile, et al.
The American Journal of Cardiology|October 26, 2024
Comparison of Outcome After Percutaneous Coronary Intervention for De Novo and In-Stent Restenosis IndicationsLars Jakobsen, Evald H Christiansen, Phillip Freeman, et al.
Pageof 49